Large granular lymphocytes from SCID horses develop potent cytotoxic activity after treatment with human recombinant interleukin 2.

Nancy S. Magnuson(Washington State University), James E. Talmadge(Nebraska Medical Center), L E Perryman(Washington State University), Carol R. Wyatt(Washington State University), P H Mason(Washington State University)
The Journal of Immunology
July 1, 1987
Cited by 32


Related Papers